Today's Research Reports on Trending Tickers: Spark Therapeutics and Akcea Therapeutics
NEW YORK, NY / ACCESSWIRE / July 3, 2018 / U.S. equities closed up on Monday, supported by a rally from the technology sector. However, growing trade concerns continue to weigh on the markets. The Dow Jones Industrial Average increased 0.15 percent to close at 24,307.18, while the S&P 500 Index jumped 0.31 percent to close at 2,726.71. The Nasdaq Composite Index climbed 0.76 percent to close at 7,567.69.
"When Trump starts talking about the WTO, China, all these big economies and these big threats, the market is going to react to that. It creates turmoil, and people are getting frustrated with all the back and forth. I think the long-term growth story of the economy remains intact, but in the meantime the trade will can cause a lot of tremors in the short term," said Mark Esposito, president of Esposito Securities, a Dallas-based asset manager.
RDI Initiates Coverage on:
Spark Therapeutics, Inc.
https://rdinvesting.com/news/?ticker=ONCE
Akcea Therapeutics, Inc.
https://rdinvesting.com/news/?ticker=AKCA
Spark Therapeutics' stock jumped 4.83% Monday, to close the day at $86.76. The stock recorded a trading volume of 388,182 shares, which was below its three months average volume of 587,656 shares. In the last year, Spark Therapeutics' shares have traded in a range of 41.06 - 94.00. The share price has gained 111.3% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $80.02 is above its 200-day moving average of $66.26. Shares of Spark Therapeutics have gained roughly 7.74 percent in the past month and are up 68.73 percent year-to-date.
Access RDI's Spark Therapeutics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=ONCE
On Monday, shares of Akcea Therapeutics recorded a trading volume of 121,269 shares, which was below the three months average volume of 293,756 shares. The stock ended the day 6.75% higher at $25.31. The share price has fallen 25.54% from its 52 week high with a 52 week trading range of 1.05 - 33.99. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $23.77 is above its 200-day moving average of $22.39. Shares of Akcea Therapeutics have gained roughly 8.07 percent in the past month and are up 45.79 percent year-to-date.
Access RDI's Akcea Therapeutics, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=AKCA
Our Actionable Research on Spark Therapeutics, Inc. (NASDAQ: ONCE) and Akcea Therapeutics, Inc. (NASDAQ: AKCA) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Nadia Noorani, CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
